Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Sabra Health Care REIT, Inc. (SBRA) SEC Filings & Earnings Calls

EquiReason read 12 Sabra Health Care REIT, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-03 — Net (loss) income attributable to Sabra Health Care REIT, Inc. $-25M; FFO attributable to Sabra Health Care REIT, Inc. $-5M; Normalized FFO attributable to Sabra Health Care REIT, .

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SBRASabra Health Care REIT, Inc.Follow SBRA — free
REIT - Healthcare Facilities · Real Estate
—
Price chart with a free account
Market cap
5.0B
P/E TTM
75.2
Dividend yield
6.1%
52-week
—
Next earnings
2 Nov, in 9 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

3 Aug 20268-K · 2.02, 7.01Net (loss) income attributable to Sabra Health Care REIT, Inc. $-25M; FFO attributable to Sabra Health Care REIT, Inc. $-5M; Normalized FFO attributable to Sabra Health Care REIT, Inc. $98M (+10% y/y); Guidance: Normalized FFO per share guiearningsopen

Figures in the filing · each found in the filing text

Net (loss) income attributable to Sabra Health Care REIT, Inc. · Consolidated · Q2-2026$-25M
FFO attributable to Sabra Health Care REIT, Inc. · Consolidated · Q2-2026$-5M
Normalized FFO attributable to Sabra Health Care REIT, Inc. · Consolidated · Q2-2026$98M+10% y/y
AFFO attributable to Sabra Health Care REIT, Inc. · Consolidated · Q2-2026$100M+12% y/y
Normalized AFFO attributable to Sabra Health Care REIT, Inc. · Consolidated · Q2-2026$103M+13% y/y
Normalized FFO per diluted common share · Consolidated · Q2-2026$0.38+3% y/y
Normalized AFFO per diluted common share · Consolidated · Q2-2026$0.40+5% y/y
Provision for loan losses and other reserves · Consolidated · Q2-2026$102M

Guidance

Normalized FFO per share guidance $1.53-$1.55; Normalized AFFO per share $1.59-$1.61.

Maintained FY2026 guidance; expects low-single-digit Cash NOI growth for triple-net and low-to-mid-teens for Senior Housing - Managed.

Risks flagged

Large provision for loan losses indicates credit quality deterioration in portfolio.

“Provision for (recovery of) loan losses and other reserves $102,445 vs ($227) prior year.” · word for word

Net loss driven by non-cash charges; core FFO growth positive.

“Net loss of $25.2M but Normalized FFO increased to $98.2M.”
Read the original on SEC EDGAR ↗
3 Aug 202610-QSabra reported a net loss of $25.2 million in Q2 2026 vs. net income of $65.5 million in Q2 2025, driven by a $100 million write-off on a mortgage loan and a $102.4 million provision for loan losses.earningsopen

Figures in the filing · each found in the filing text

Total revenues · Q2-2026$236M+25% y/y
Net (loss) income attributable to Sabra Health Care REIT, Inc. · Q2-2026$-25M-138% y/y
Net cash provided by operating activities · H1-2026$184M+14% y/y
Dividend per share · Q2-2026$0.300% y/y
Number of properties · 2026-06-30364

Risks flagged

Large credit loss on mortgage loan

“On June 30, 2026, the Company received a reduced cash payment of $200.0 million in full satisfaction of the $300.0 million Recovery Centers of America mortgage loan, resulting in a write-off of $100.0 million.” · word for word

Elevated provision for loan losses

“Provision for (recovery of) loan losses and other reserves $ 102,445 $ (227)”

Net loss in Q2 2026

“Net (loss) income attributable to Sabra Health Care REIT, Inc. $ (25,202) $ 65,542” · word for word
Read the original on SEC EDGAR ↗
21 Jul 20268-K · 7.01G&A expenses $61M; Cash interest expense $104M; Weighted average share count (Normalized FFO) 258,000,000; Guidance: Normalized FFO per share midpoint $1.54, up 7% YoY; Normalized AFFO per share midpoint $1.60, up 8% YoY.open

Figures in the filing · each found in the filing text

G&A expenses · FY2026$61M
Cash interest expense · FY2026$104M
Weighted average share count (Normalized FFO) · FY2026258,000,000
Weighted average share count (Normalized AFFO) · FY2026259,000,000
Annualized cash rent (Avamere portfolio) · Avamere Portfolio$53M+29% y/y

Guidance

Normalized FFO per share midpoint $1.54, up 7% YoY; Normalized AFFO per share midpoint $1.60, up 8% YoY.

Raised full-year 2026 guidance driven by portfolio re-tenanting, rent increases, and debt reduction.

Risks flagged

Avamere transition execution risk; tenant transitions may face delays or operational issues.

“Transition is expected to be completed during the second half of 2026.” · word for word
Read the original on SEC EDGAR ↗
28 May 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportSEC ↗
29 Apr 202610-QRevenue $222M (+21% y/y); Net income $41M (+1% y/y); Operating cash flow $98M (+23% y/y)open

Figures in the filing · each found in the filing text

Revenue · Q1-2026$222M+21% y/y
Net income · Q1-2026$41M+1% y/y
Operating cash flow · Q1-2026$98M+23% y/y
Dividend per share · Q1-2026$0.300% y/y
Total debt · 2026-03-31$2.69B
Number of properties · 2026-03-31361
Acquisitions · Q1-2026$96M

Risks flagged

Interest rate exposure

“Interest expense increased to $28.4M from $27.1M YoY; significant variable-rate debt on revolving credit facility.”

Operating cost inflation in managed portfolio

“Senior housing - managed portfolio operating expenses increased to $81.9M from $56.5M YoY, outpacing revenue growth.”
Read the original on SEC EDGAR ↗
29 Apr 20268-K · 2.02, 7.01Sabra Health Care REIT reported Q1 2026 results: Normalized FFO per share $0.38 vs $0.35 YoY, AFFO per share $0.39 vs $0.37 YoY. Net income $40.9M vs $40.3M. Net Debt to Adjusted EBITDA 5.04x. No guidance provided.earningsopen

Figures in the filing · each found in the filing text

Net income · Q1-2026$41M+1% y/y

Risks flagged

No material risk signals identified in this earnings release.

Read the original on SEC EDGAR ↗
24 Apr 2026DEF 14AProxy statement for 2026 Annual Meeting of Stockholders, disclosing executive compensation, governance practices, and financial highlights.open

Figures in the filing · each found in the filing text

Adjusted Normalized FFO Per Share · FY2025$1.53+4% y/y
Net Debt to Adjusted EBITDA · FY2025$5.00-5% y/y
Total Shareholder Return · FY202517.0%
New Investments · FY2025$450M
Liquidity · 2025-12-31$1.20B
Net Income · FY2025$156M+23% y/y
Total Debt · 2025-12-31$2.55B+5% y/y
Acquisitions · FY2025$450M

Risks flagged

Key person succession risk mitigated

“Ms. Nevo-Hacohen retired effective December 31, 2025, and currently serves in a consulting role for Sabra to ensure her many years of expertise provide ongoing continuity for the investment function.” · word for word
Read the original on SEC EDGAR ↗
12 Feb 202610-KNumber of Properties 360; Total Debt $2.60B; Revolving Credit Facility Availability $782Mopen

Figures in the filing · each found in the filing text

Number of Properties · FY2025360
Total Debt · FY2025$2.60B
Revolving Credit Facility Availability · FY2025$782M

Risks flagged

Interest Rate Sensitivity

“An increase in market interest rates could increase our interest costs on borrowings on our Revolving Credit Facility and future debt and could adversely affect our stock price.” · word for word

Labor Cost and Shortage

“A shortage of caregivers or other trained personnel, minimum staffing requirements or general inflationary pressures on wages has and may continue to force tenants, borrowers and Senior Housing - Managed communities to enhance pay and benefits packages to compete effectively for skilled personnel” · word for word

Reimbursement Risk

“The reduction in reimbursement rates from third-party payors, including insurance companies and the Medicare and Medicaid programs, or other measures reducing reimbursements for services provided by our tenants and borrowers, may result in a reduction in our tenants’ and borrowers’ revenues and operating margins.” · word for word
Read the original on SEC EDGAR ↗
12 Feb 20268-K · 2.02, 7.01General and administrative expenses $52M; Cash interest expense $103M; Weighted average share count for Normalized FFO 255,000,000; Guidance: Normalized FFO per share $1.49-$1.53; Normalized AFFO per share $1.55-$1.59earningsopen

Figures in the filing · each found in the filing text

General and administrative expenses · FY2026$52M
Cash interest expense · FY2026$103M
Weighted average share count for Normalized FFO · FY2026255,000,000
Weighted average share count for Normalized AFFO · FY2026256,000,000

Guidance

Normalized FFO per share $1.49-$1.53; Normalized AFFO per share $1.55-$1.59

2026 guidance reflects strong same-store growth in senior housing managed portfolio and stable FFO/AFFO metrics.

Risks flagged

Guidance assumes no tenants placed on cash-basis or moved to accrual-basis after Dec 31, 2025

“no tenants are placed on cash-basis or moved to accrual-basis for revenue recognition after December 31, 2025” · word for word
Read the original on SEC EDGAR ↗
5 Jan 20268-K · 5.02, 7.01Base Salary $470,000.00open

Figures in the filing · each found in the filing text

Base Salary · FY2026$470000.00
Read the original on SEC EDGAR ↗
5 Nov 20258-K · 2.02, 7.01Normalized FFO per share $0.36 (+3% y/y); Normalized AFFO per share $0.38 (+3% y/y); Net income per share $0.09 (-31% y/y); Guidance: Normalized FFO guidance midpoint raised to $1.46 from $1.455earningsopen

Figures in the filing · each found in the filing text

Normalized FFO per share · Q3-2025$0.36+3% y/y
Normalized AFFO per share · Q3-2025$0.38+3% y/y
Net income per share · Q3-2025$0.09-31% y/y
FFO per share · Q3-2025$0.33-3% y/y
Normalized FFO guidance midpoint · FY2025$1.46
Normalized AFFO guidance midpoint · FY2025$1.50

Guidance

Normalized FFO guidance midpoint raised to $1.46 from $1.455

2025 Normalized FFO guidance raised slightly, reflecting improved senior housing performance.

Risks flagged

Tenant credit risk from potential cash-basis revenue recognition changes.

“Guidance assumes no tenants are placed on cash-basis or moved to accrual-basis after September 30, 2025.”
Read the original on SEC EDGAR ↗
5 Nov 202510-QSabra reported Q3 2025 results with revenue growth but net income decline due to higher costs and impairments.earningsopen

Figures in the filing · each found in the filing text

Total revenues · Q3-2025$190M+7% y/y
Net income attributable to Sabra Health Care REIT, Inc. · Q3-2025$23M-24% y/y
Cash and cash equivalents · 2025-09-30$201M
Number of properties · 2025-09-30363
Dividend per share · Q3-2025$0.300% y/y
Acquisitions (real estate) · 9M-2025$283M+152% y/y

Risks flagged

Impairment risk from portfolio repositioning

“The Company continues to evaluate additional assets for sale as part of its initiative to recycle capital and further improve its portfolio quality. This could lead to a shorter hold period for such assets and could result in the determination that the full amount of the Company's investment in such assets is not recoverable, resulting in an impairment charg” · word for word

Interest rate exposure

“Unrealized loss on cash flow hedges of $28.9 million for the nine months ended September 30, 2025.”
Read the original on SEC EDGAR ↗

Sabra Health Care REIT, Inc. — questions

What did Sabra Health Care REIT, Inc. file recently?
12 SEC filings in the last 12 months. Latest: 8-K on 2026-08-03 — Net (loss) income attributable to Sabra Health Care REIT, Inc. $-25M; FFO attributable to Sabra Health Care REIT, Inc. $-5M; Normalized FFO attributable to Sabra Health Care REIT, Inc. $98M (+10% y/y); Guidance: Normalized FFO per share gui

Every figure on this page comes from Sabra Health Care REIT, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.